Koninklijke Philips N.V. logo

Koninklijke Philips N.V. (PHG)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
25. 74
+0.25
+0.9808%
$
24.44B Market Cap
- P/E Ratio
1% Div Yield
1.34M Volume
1.37 Eps
$ 25.49
Previous Close
Add Transaction
Day Range
25.72 26.05
Year Range
23.62 33.44
Want to track PHG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Royal Philips (PHG) is a Strong Value Stock

Here's Why Royal Philips (PHG) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Should Value Investors Buy Koninklijke Philips (PHG) Stock?

Should Value Investors Buy Koninklijke Philips (PHG) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 years ago
Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 years ago
Are You Looking for a Top Momentum Pick? Why Royal Philips (PHG) is a Great Choice

Are You Looking for a Top Momentum Pick? Why Royal Philips (PHG) is a Great Choice

Does Royal Philips (PHG) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 2 years ago
PHG vs. ESLOY: Which Stock Is the Better Value Option?

PHG vs. ESLOY: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Royal Philips (PHG) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 2 years ago
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term

Why Royal Philips (PHG) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 2 years ago
Should Value Investors Buy Koninklijke Philips (PHG) Stock?

Should Value Investors Buy Koninklijke Philips (PHG) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 years ago
PHG or ESLOY: Which Is the Better Value Stock Right Now?

PHG or ESLOY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Products sector might want to consider either Royal Philips (PHG) or EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 2 years ago
Polarean Imaging appoints Philips Healthcare veteran as sales vice president

Polarean Imaging appoints Philips Healthcare veteran as sales vice president

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) has appointed Alan Huang, formerly of Philips Healthcare, as the firm's new sales vice president. Having served at Philips for 12 years and as its MRI business units' North American head most recently, Huang joins Polaren following over a year of collaboration between the two firms.

Proactiveinvestors | 2 years ago
Philips (PHG) Extends Isala Partnership, Boosts Customer Base

Philips (PHG) Extends Isala Partnership, Boosts Customer Base

Philips (PHG) extends its partnership Isala hospital to optimize the latter's healthcare processes, expanding its customer base.

Zacks | 2 years ago
Philips (PHG) Q2 Earnings Rise, Revenues Fall Year Over Year

Philips (PHG) Q2 Earnings Rise, Revenues Fall Year Over Year

Philips' (PHG) second-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses.

Zacks | 2 years ago
Philips Q2 Earnings: A Focus On Core Strengths Is The Winning Strategy

Philips Q2 Earnings: A Focus On Core Strengths Is The Winning Strategy

We recap the Q2 earnings report from Philips highlighted by comparable sales growth and a rebound in new orders. The company is settling litigation related to the global safety recall of its defective respiratory sleep apnea products. Improving financials and declining uncertainties support a positive outlook for the stock.

Seekingalpha | 2 years ago
Loading...
Load More